Selective and orally bioavailable phenylglycine tissue factor/factor VIIa inhibitors

被引：31

作者：

Zbinden, KG ^{[1
]}

Obst-Sander, U ^{[1
]}

Hilpert, K ^{[1
]}

Kühne, H ^{[1
]}

Banner, DW ^{[1
]}

Böhm, HJ ^{[1
]}

Stahl, M ^{[1
]}

Ackermann, J ^{[1
]}

Alig, L ^{[1
]}

Weber, L ^{[1
]}

Wessel, HP ^{[1
]}

Riederer, MA ^{[1
]}

Tschopp, TB ^{[1
]}

Lavé, T ^{[1
]}

机构：

[1] F Hoffmann La Roche & Co Ltd, CH-4070 Basel, Switzerland

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2005年 / 15卷 / 23期

关键词：

D O I：

10.1016/j.bmcl.2005.04.079

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

We describe the structure-based design and synthesis of highly potent, orally bioavailable tissue factor/factor Vila inhibitors which interfere with the coagulation cascade by selective inhibition of the extrinsic pathway. (c) 2005 Elsevier Ltd. All rights reserved.

引用

页码：5344 / 5352

页数：9

共 48 条

[1] Redefining medical treatment in the management of unstable angina
Braunwald, E
Califf, RM
Cannon, CP
Fox, KAA
Fuster, V
Gibler, WB
Harrington, RA
King, SB
Kleiman, NS
Theroux, P
Topol, EJ
Van de Werf, F
White, HD
Willerson, JT
[J]. AMERICAN JOURNAL OF MEDICINE, 2000, 108 (01) : 41 - 53
[2] Dysinosin a:: A novel inhibitor of factor Vila and thrombin from a new genus and species of Australian sponge of the family dysideidae
Carroll, AR
Pierens, GK
Fechner, G
de Almeida Leone, P
Ngo, A
Simpson, M
Hyde, E
Hooper, JNA
Boström, SL
Musil, D
Quinn, RJ
[J]. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2002, 124 (45) : 13340 - 13341
[3] The structure of Staphylococcus aureus epidermolytic toxin A, an atypic serine protease, at 1.7 angstrom resolution
Cavarelli, J
Prevost, G
Bourguet, W
Moulinier, L
Chevrier, B
Delagoutte, B
Bilwes, A
Mourey, L
Rifai, S
Piemont, Y
Moras, D
[J]. STRUCTURE, 1997, 5 (06) : 813 - 824
[4] Ximelagatran: the first oral direct thrombin inhibitor
Crowther, MA
Weitz, JI
[J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (04) : 403 - 413
[5] DEGUZMAN L, 1997, THROMB HAEMOST S, V292
[6] Edgington TS, 1997, THROMB HAEMOSTASIS, V78, P401
[7] The factor VII zymogen structure reveals reregistration of β strands during activation
Eigenbrot, C
Kirchhofer, D
Dennis, MS
Santell, L
Lazarus, RA
Stamos, J
Ultsch, MH
[J]. STRUCTURE, 2001, 9 (07) : 627 - 636
[8] Ximelagatran and melagatran compared with dalteparin for prevention of venous thromboembolism after total hip or knee replacement:: the METHRO II randomised trial
Eriksson, B
Bergqvist, D
Kälebo, P
Dahl, OE
Lindbratt, S
Bylock, A
Frison, L
Eriksson, UG
Welin, L
Gustafsson, D
[J]. LANCET, 2002, 360 (9344) : 1441 - 1447
[9] Golino P, 1998, CIRC RES, V82, P39
[10] Targeting thrombin and factor VIIa: Design, synthesis, and inhibitory activity of functionally relevant indolizidinones
Hanessian, S
Therrien, E
Granberg, K
Nilsson, I
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2002, 12 (20) : 2907 - 2911

← 1 2 3 4 5 →